Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tss (TSSI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Tss (TSSI) over the last 17 years, with Q3 2025 value amounting to $75.7 million.

  • Tss' Cash & Equivalents rose 6296.93% to $75.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.7 million, marking a year-over-year increase of 6296.93%. This contributed to the annual value of $23.2 million for FY2024, which is 9628.1% up from last year.
  • Per Tss' latest filing, its Cash & Equivalents stood at $75.7 million for Q3 2025, which was up 6296.93% from $36.8 million recorded in Q2 2025.
  • Over the past 5 years, Tss' Cash & Equivalents peaked at $75.7 million during Q3 2025, and registered a low of $6.7 million during Q1 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $12.8 million (2022), whereas its average is $20.6 million.
  • In the last 5 years, Tss' Cash & Equivalents plummeted by 6561.72% in 2024 and then skyrocketed by 34321.98% in 2025.
  • Quarter analysis of 5 years shows Tss' Cash & Equivalents stood at $8.0 million in 2021, then surged by 155.22% to $20.4 million in 2022, then plummeted by 42.0% to $11.8 million in 2023, then skyrocketed by 96.28% to $23.2 million in 2024, then skyrocketed by 225.97% to $75.7 million in 2025.
  • Its Cash & Equivalents stands at $75.7 million for Q3 2025, versus $36.8 million for Q2 2025 and $27.3 million for Q1 2025.